225 related articles for article (PubMed ID: 38351394)
1. Recombinant Human Keratinocyte Growth Factor Ameliorates Cancer Treatment-Induced Oral Mucositis on a Chip.
Ly KL; Rajtboriraks M; Elgerbi A; Luo X; Raub CB
Adv Healthc Mater; 2024 Jun; 13(14):e2302970. PubMed ID: 38351394
[TBL] [Abstract][Full Text] [Related]
2. Oral mucositis on a chip: modeling induction by chemo- and radiation treatments and recovery.
Ly KL; Luo X; Raub CB
Biofabrication; 2022 Oct; 15(1):. PubMed ID: 36126642
[TBL] [Abstract][Full Text] [Related]
3. Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro.
Hille A; Grüger S; Christiansen H; Wolff HA; Volkmer B; Lehmann J; Dörr W; Rave-Fränk M
Radiat Environ Biophys; 2010 May; 49(2):261-70. PubMed ID: 20213138
[TBL] [Abstract][Full Text] [Related]
4. Azilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model.
de Araújo AA; Varela H; de Medeiros CA; de Castro Brito GA; de Lima KC; de Moura LM; de Araújo Júnior RF
PLoS One; 2015; 10(2):e0116799. PubMed ID: 25689279
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte growth factor expression in human gingival fibroblasts and stimulation of in vitro gene expression by retinoic acid.
Mackenzie IC; Gao Z
J Periodontol; 2001 Apr; 72(4):445-53. PubMed ID: 11338296
[TBL] [Abstract][Full Text] [Related]
6. Palifermin: in myelotoxic therapy-induced oral mucositis.
Siddiqui MA; Wellington K
Drugs; 2005; 65(15):2139-46; discussion 2147-9. PubMed ID: 16225371
[TBL] [Abstract][Full Text] [Related]
7. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair.
Finch PW; Rubin JS
Adv Cancer Res; 2004; 91():69-136. PubMed ID: 15327889
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte growth factor in focus: A comprehensive review from structural and functional aspects to therapeutic applications of palifermin.
Sadeghi S; Kalhor H; Panahi M; Abolhasani H; Rahimi B; Kalhor R; Mehrabi A; Vahdatinia M; Rahimi H
Int J Biol Macromol; 2021 Nov; 191():1175-1190. PubMed ID: 34606789
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte growth factor (KGF)-1 and -2 protein and gene expression in human gingival fibroblasts.
Sanale AR; Firth JD; Uitto VJ; Putnins EE
J Periodontal Res; 2002 Feb; 37(1):66-74. PubMed ID: 11842940
[TBL] [Abstract][Full Text] [Related]
10. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo.
Ning S; Shui C; Khan WB; Benson W; Lacey DL; Knox SJ
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):177-87. PubMed ID: 9422575
[TBL] [Abstract][Full Text] [Related]
11. Effect of nifedipine on the expression of keratinocyte growth factor and its receptor in cocultured/monocultured fibroblasts and keratinocytes.
Di CP; Sun Y; Zhao L; Li L; Ding C; Xu Y; Fan Y
J Periodontal Res; 2013 Dec; 48(6):740-7. PubMed ID: 23528007
[TBL] [Abstract][Full Text] [Related]
12. Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors.
Riley P; Glenny AM; Worthington HV; Littlewood A; Fernandez Mauleffinch LM; Clarkson JE; McCabe MG
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011990. PubMed ID: 29181845
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte growth factor and scatter factor expression by regionally defined oral fibroblasts.
McKeown ST; Hyland PL; Locke M; Mackenzie IC; Irwin CR
Eur J Oral Sci; 2003 Feb; 111(1):42-50. PubMed ID: 12558807
[TBL] [Abstract][Full Text] [Related]
14. An overview on keratinocyte growth factor: from the molecular properties to clinical applications.
Yen TT; Thao DT; Thuoc TL
Protein Pept Lett; 2014 Mar; 21(3):306-17. PubMed ID: 24188496
[TBL] [Abstract][Full Text] [Related]
15. Oral fibroblasts produce more HGF and KGF than skin fibroblasts in response to co-culture with keratinocytes.
Grøn B; Stoltze K; Andersson A; Dabelsteen E
APMIS; 2002 Dec; 110(12):892-8. PubMed ID: 12645668
[TBL] [Abstract][Full Text] [Related]
16. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
Radtke ML; Kolesar JM
J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
[TBL] [Abstract][Full Text] [Related]
17. Effects of palifermin on antitumor activity of chemotherapeutic and biological agents in human head and neck and colorectal carcinoma xenograft models.
Brake R; Starnes C; Lu J; Chen D; Yang S; Radinsky R; Borges L
Mol Cancer Res; 2008 Aug; 6(8):1337-46. PubMed ID: 18708365
[TBL] [Abstract][Full Text] [Related]
18. A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis.
Wu X; Chen P; Sonis ST; Lingen MW; Berger A; Toback FG
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e409-15. PubMed ID: 22420966
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the keratinocyte-fibroblast paracrine relationship with gelatin-based semi-interpenetrating networks containing bioactive factors for wound repair.
Bader RA; Kao WJ
J Biomater Sci Polym Ed; 2009; 20(7-8):1005-30. PubMed ID: 19454166
[TBL] [Abstract][Full Text] [Related]
20. Cell kinetic studies in the murine ventral tongue epithelium: mucositis induced by radiation and its protection by pretreatment with keratinocyte growth factor (KGF).
Potten CS; Booth D; Cragg NJ; Tudor GL; O'Shea JA; Booth C; Meineke FA; Barthel D; Loeffler M
Cell Prolif; 2002 Aug; 35 Suppl 1():32-47. PubMed ID: 12139706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
